Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte

References

• Nakayama H, Chen X, Baines CP et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest.117, 2431–2444 (2007).
   PubMed Web of Science ®Google Scholar
• Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol. Biochem.20, 1–22 (2007).
   PubMed Web of Science ®Google Scholar
• Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J. Biol. Chem.282, 8069–8078 (2007).
   PubMed Web of Science ®Google Scholar
• Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol.69, 51–67 (2007).
   PubMed Web of Science ®Google Scholar
• Das DK, Maulik N. Mitochondrial function in cardiomyocytes: target for cardioprotection. Curr. Opin. Anaesthesiol.18, 77–82 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang D, Mott JL, Chang SW, Stevens M, Mikolajczak P, Zassenhaus HP. Mitochondrial DNA mutations activate programmed cell survival in the mouse heart. Am. J. Physiol. Heart Circ. Physiol.288, H2476–H2483 (2005).
   Google Scholar
• Imahashi K, Schneider MD, Steenbergen C, Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res.95, 734–741 (2004).
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia–reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc. Res.61, 448–460 (2004).
   PubMed Web of Science ®Google Scholar
• McFalls EO, Liem D, Schoonderwoerd K, Lamers J, Sluiter W, Duncker D. Mitochondrial function: the heart of myocardial preservation. J. Lab. Clin. Med.142, 141–148 (2003).
   PubMed Web of Science ®Google Scholar
• Adams JW, Pagel AL, Means CK, Oksenberg D, Armstrong RC, Brown JH. Cardiomyocyte apoptosis induced by Gαq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ. Res.87, 1180–1187 (2000).
   PubMed Web of Science ®Google Scholar
• Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc. Res.77, 334–343 (2008).
   PubMed Web of Science ®Google Scholar
• Horbinski C, Chu CT. Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic. Biol. Med.38, 2–11 (2005).
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med.15, 69–75 (2005).
   PubMed Web of Science ®Google Scholar
• Kowalczyk JE, Zablocka B. [Protein kinases in mitochondria]. Postepy Biochem.54, 209–216 (2008).
   PubMedGoogle Scholar
• Li Y, Sato T. Dual signaling via protein kinase C and phosphatidylinositol 3´-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J. Mol. Cell. Cardiol.33, 2047–2053 (2001).
   PubMed Web of Science ®Google Scholar
• Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem.279, 47985–47991 (2004).
   PubMed Web of Science ®Google Scholar
• Ohori K, Miura T, Tanno M et al. Ser9 phosphorylation of mitochondrial GSK-3β is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am. J. Physiol. Heart Circ. Physiol.295, H2079–H2086 (2008).
   Google Scholar
• Park SS, Zhao H, Mueller RA, Xu Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3β. J. Mol. Cell. Cardiol.40, 708–716 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen MV, Philipp S, Krieg T et al. Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J. Mol. Cell. Cardiol.42, 842–851 (2007).
   PubMed Web of Science ®Google Scholar
• Das M, Gherghiceanu M, Lekli I, Mukherjee S, Popescu LM, Das DK. Essential role of lipid raft in ischemic preconditioning. Cell Physiol. Biochem.21, 325–334 (2008).
   PubMedGoogle Scholar
• Downey JM, Krieg T, Cohen MV. Mapping preconditioning’s signaling pathways: an engineering approach. Ann. NY Acad. Sci.1123, 187–196 (2008).
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta1767, 1007–1031 (2007).
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Engelman RM, Maulik N, Das DK. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation109, 3042–3049 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Park TS, Gidday JM. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. Heart Circ. Physiol.292, H2573–H2581 (2007).
   Google Scholar
• Smart N, Mojet MH, Latchman DS, Marber MS, Duchen MR, Heads RJ. IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovasc. Res.69, 164–177 (2006).
   PubMed Web of Science ®Google Scholar
• Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br. J. Pharmacol.149, 5–13 (2006).
   PubMed Web of Science ®Google Scholar
• Lai HC, Liu TJ, Ting CT, Sharma PM, Wang PH. Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway. Mol. Cell. Endocrinol.205, 99–106 (2003).
   PubMed Web of Science ®Google Scholar
• Satoh M, Matter CM, Ogita H et al. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation115, 3197–3204 (2007).
   PubMed Web of Science ®Google Scholar
• Tissier R, Waintraub X, Couvreur N et al. Pharmacological postconditioning with the phytoestrogen genistein. J. Mol. Cell. Cardiol.42, 79–87 (2007).
   PubMed Web of Science ®Google Scholar
• Lai HC, Liu TJ, Ting CT et al. Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60. Am. J. Physiol. Endocrinol. Metab.292, E292–E297 (2007).
   PubMed Web of Science ®Google Scholar
• Ahmad N, Wang Y, Haider KH et al. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am. J. Physiol. Heart Circ. Physiol.290, H2402–H2408 (2006).
   Google Scholar
• Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int. J. Biochem. Cell Biol.38, 414–419 (2006).
   PubMed Web of Science ®Google Scholar
• Juhaszova M, Zorov DB, Kim SH et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest.113, 1535–1549 (2004).
   PubMed Web of Science ®Google Scholar
• Bhamra GS, Hausenloy DJ, Davidson SM et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res. Cardiol.103, 274–284 (2008).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Miura T, Ishida H et al. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin. Exp. Pharmacol. Physiol.35, 812–819 (2008).
   PubMed Web of Science ®Google Scholar
• Nagy N, Malik G, Tosaki A, Ho YS, Maulik N, Das DK. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J. Mol. Cell. Cardiol.44, 252–260 (2008).
   PubMed Web of Science ®Google Scholar
• Hui ST, Andres AM, Miller AK et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl Acad. Sci. USA105, 3921–3926 (2008).
   PubMed Web of Science ®Google Scholar
• Philipp S, Critz SD, Cui L, Solodushko V, Cohen MV, Downey JM. Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning’s trigger pathway. Basic Res. Cardiol.101, 159–167 (2006).
   PubMed Web of Science ®Google Scholar
• Sahach VF, Korkach Iu P, Kotsiuruba AV, Rudyk OV, Vavilova HL. [Mitochondrial permeability transition pore opening inhibition by ecdysterone in heart mitochondria of aging rats]. Fiziol. Zh.54, 3–10 (2008).
   Google Scholar
• Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson C, Boysen PG. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc. Res.65, 803–812 (2005).
   PubMed Web of Science ®Google Scholar
• Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J. Neurochem.87, 1427–1435 (2003).
   PubMed Web of Science ®Google Scholar
• Sasaki K, Sato M, Umezawa Y. Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells. J. Biol. Chem.278, 30945–30951 (2003).
   PubMed Web of Science ®Google Scholar
• Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res.103, 1232–1240 (2008).
   PubMed Web of Science ®Google Scholar
• Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: AKTing on apoptosis. Cell Signal20, 21–30 (2008).
   PubMed Web of Science ®Google Scholar
• Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell91, 231–241 (1997).
   PubMed Web of Science ®Google Scholar
• Pastukh V, Ricci C, Solodushko V, Mozaffari M, Schaffer SW. Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning. Mol. Cell. Biochem.269, 59–67 (2005).
   PubMed Web of Science ®Google Scholar
• Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol.285, H1506–H1514 (2003).
   PubMed Web of Science ®Google Scholar
• Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ. Res.89, 1191–1198 (2001).
   PubMed Web of Science ®Google Scholar
• Negoro S, Oh H, Tone E et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation103, 555–561 (2001).
   PubMed Web of Science ®Google Scholar
• Kuwahara K, Saito Y, Kishimoto I et al. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J. Mol. Cell. Cardiol.32, 1385–1394 (2000).
   PubMed Web of Science ®Google Scholar
• Le Bras M, Rouy I, Brenner C. The modulation of inter-organelle cross-talk to control apoptosis. Med. Chem.2, 1–12 (2006).
   PubMedGoogle Scholar
• Robey RB, Hay N. Mitochondrial hexokinases: guardians of the mitochondria. Cell Cycle4, 654–658 (2005).
   PubMed Web of Science ®Google Scholar
• Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene25, 4683–4696 (2006).
   PubMed Web of Science ®Google Scholar
• Birnbaum MJ. On the InterAktion between hexokinase and the mitochondrion. Dev. Cell7, 781–782 (2004).
   PubMed Web of Science ®Google Scholar
• Majewski N, Nogueira V, Bhaskar P et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell16, 819–830 (2004).
   PubMed Web of Science ®Google Scholar
• Majewski N, Nogueira V, Robey RB, Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol.24, 730–740 (2004).
   PubMed Web of Science ®Google Scholar
• Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev.15, 1406–1418 (2001).
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ.15(3), 521–529 (2008).
   PubMed Web of Science ®Google Scholar
• Walsh K. Akt signaling and growth of the heart. Circulation113, 2032–2034 (2006).
   PubMed Web of Science ®Google Scholar
• Shiraishi I, Melendez J, Ahn Y et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ. Res.94, 884–891 (2004).
   PubMed Web of Science ®Google Scholar
• Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia–reperfusion injury in mouse heart. Circulation101, 660–667 (2000).
   PubMed Web of Science ®Google Scholar
• Bullock AN, Debreczeni J, Amos AL, Knapp S, Turk BE. Structure and substrate specificity of the Pim-1 kinase. J. Biol. Chem.280, 41675–41682 (2005).
   PubMed Web of Science ®Google Scholar
• Hoover D, Friedmann M, Reeves R, Magnuson NS. Recombinant human Pim-1 protein exhibits serine/threonine kinase activity. J. Biol. Chem.266, 14018–14023 (1991).
   PubMed Web of Science ®Google Scholar
• Wang Z, Bhattacharya N, Weaver M et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci.2, 167–179 (2001).
   PubMedGoogle Scholar
• Bachmann M, Moroy T. The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol.37, 726–730 (2005).
   PubMed Web of Science ®Google Scholar
• Mally MI, Vogt M, Swift SE, Haas M. Oncogene expression in murine splenic T cells and in murine T-cell neoplasms. Virology144, 115–126 (1985).
   PubMed Web of Science ®Google Scholar
• Nagarajan L, Louie E, Tsujimoto Y, ar-Rushdi A, Huebner K, Croce CM. Localization of the human Pim oncogene (PIM) to a region of chromosome 6 involved in translocations in acute leukemias. Proc. Natl Acad. Sci. USA83, 2556–2560 (1986).
   PubMed Web of Science ®Google Scholar
• Meeker TC, Nagarajan L, ar-Rushdi A, Rovera G, Huebner K, Croce CM. Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family. Oncogene Res.1, 87–101 (1987).
   PubMedGoogle Scholar
• Stewart BE, Rice RH. Differentiation-associated expression of the proto-oncogene Pim-1 in cultured human keratinocytes. J. Invest. Dermatol.105, 699–703 (1995).
   PubMed Web of Science ®Google Scholar
• Liang H, Hittelman W, Nagarajan L. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. Arch. Biochem. Biophys.330, 259–265 (1996).
   PubMed Web of Science ®Google Scholar
• Leduc I, Karsunky H, Mathieu N et al. The Pim-1 kinase stimulates maturation of TCRβ-deficient T cell progenitors: implications for the mechanism of Pim-1 action. Int. Immunol.12, 1389–1396 (2000).
   PubMed Web of Science ®Google Scholar
• Ellwood-Yen K, Graeber TG, Wongvipat J et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell4, 223–238 (2003).
   PubMed Web of Science ®Google Scholar
• Katakami N, Kaneto H, Hao H et al. Role of Pim-1 in smooth muscle cell proliferation. J. Biol. Chem.279, 54742–54749 (2004).
   PubMed Web of Science ®Google Scholar
• Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and Pim-1 genes in human T cells. Blood93, 1980–1991 (1999).
   PubMed Web of Science ®Google Scholar
• Paukku K, Silvennoinen O. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev.15, 435–455 (2004).
   PubMed Web of Science ®Google Scholar
• Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol.173, 6409–6417 (2004).
   PubMed Web of Science ®Google Scholar
• Krishnan N, Pan H, Buckley DJ, Buckley A. Prolactin-regulated Pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine20, 123–130 (2003).
   PubMed Web of Science ®Google Scholar
• Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett.571, 43–49 (2004).
   PubMed Web of Science ®Google Scholar
• Yan B, Zemskova M, Holder S et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J. Biol. Chem.278, 45358–45367 (2003).
   PubMed Web of Science ®Google Scholar
• Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest.115, 2618–2624 (2005).
   PubMed Web of Science ®Google Scholar
• Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood105, 4477–4483 (2005).
   PubMed Web of Science ®Google Scholar
• Jacobs MD, Black J, Futer O et al. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J. Biol. Chem.280, 13728–13734 (2005).
   PubMed Web of Science ®Google Scholar
• Kunkel MT, Ni Q, Tsien RY, Zhang J, Newton AC. Spatio–temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J. Biol. Chem.280, 5581–5587 (2005).
   PubMed Web of Science ®Google Scholar
• Camper-Kirby D, Welch S, Walker A et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res.88, 1020–1027 (2001).
   PubMed Web of Science ®Google Scholar
• Muraski JA, Rota M, Misao Y et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat. Med.13, 1467–1475 (2007).
   PubMed Web of Science ®Google Scholar
• Muraski JA, Fischer KM, Wu W et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc. Natl Acad. Sci. USA105, 13889–13894 (2008).
   PubMed Web of Science ®Google Scholar
• Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev.17, 1841–1854 (2003).
   PubMed Web of Science ®Google Scholar
• Kim KT, Levis M, Small D. Constitutively activated FLT3 phosphorylates BAD partially through Pim-1. Br. J. Haematol.134, 500–509 (2006).
   PubMed Web of Science ®Google Scholar
• Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene18, 4022–4031 (1999).
   PubMed Web of Science ®Google Scholar
• Condorelli G, Drusco A, Stassi G et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl Acad. Sci. USA99, 12333–12338 (2002).
   PubMed Web of Science ®Google Scholar
• Matsui T, Li L, Wu JC, Cook SA et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem.277, 22896–22901 (2002).
   PubMed Web of Science ®Google Scholar
• Matsui T, Nagoshi T, Hong EG et al. Effects of chronic Akt activation on glucose uptake in the heart. Am. J. Physiol. Endocrinol. Metab.290, E789–E797 (2006).
   Google Scholar
• Nagoshi T, Matsui T, Aoyama T et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest.115, 2128–2138 (2005).
   PubMed Web of Science ®Google Scholar
• Shiojima I, Sato K, Izumiya Y et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest.115, 2108–2118 (2005).
   PubMed Web of Science ®Google Scholar
• Shioi T, McMullen JR, Kang PM et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol.22, 2799–2809 (2002).
   PubMed Web of Science ®Google Scholar
• Grandemange S, Herzig S, Martinou JC. Mitochondrial dynamics and cancer. Semin. Cancer Biol.19(1), 50–56 (2009).
   PubMed Web of Science ®Google Scholar
• Herzig S, Martinou JC. Mitochondrial dynamics: to be in good shape to survive. Curr. Mol. Med.8, 131–137 (2008).
   PubMed Web of Science ®Google Scholar
• Westermann B. Molecular machinery of mitochondrial fusion and fission. J. Biol. Chem.283, 13501–13505 (2008).
   PubMed Web of Science ®Google Scholar
• Berman SB, Pineda FJ, Hardwick JM. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ.15, 1147–1152 (2008).
   PubMed Web of Science ®Google Scholar
• Devenish RJ. Mitophagy: growing in intricacy. Autophagy3, 293–294 (2007).
   PubMed Web of Science ®Google Scholar
• Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res.8, 3–5 (2005).
   PubMed Web of Science ®Google Scholar
• Mijaljica D, Prescott M, Devenish RJ. Different fates of mitochondria: alternative ways for degradation? Autophagy3, 4–9 (2007).
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Rubio M, Sussman MA. Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc. Res.82(2), 272–285 (2009).
   PubMed Web of Science ®Google Scholar
• White E. The Pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev.17, 1813–1816 (2003).
   PubMed Web of Science ®Google Scholar